{"id":"W2970201384","doi":"10.1093/eurheartj/ehz404","title":"Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"Medicine; Rivaroxaban; Aspirin; Cohort; Myocardial infarction; Stroke (engine); Internal medicine; Hazard ratio; Warfarin; Surgery; Confidence interval; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000674,0.0001912419,0.000523749,0.00006967774,0.000308624,0.0001130117,0.000153011,0.00002466706,0.00002722101],"category_scores_gemma":[0.0004478906,0.0001238101,0.0004991922,0.0001250142,0.00004710408,0.0001335659,0.00008613413,0.0002809608,0.00001223419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002322234,"about_ca_system_score_gemma":0.00006287846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001959,"about_ca_topic_score_gemma":4.30009e-7,"domain_scores_codex":[0.9979196,0.0003109319,0.0004142543,0.0003182882,0.0007478962,0.0002890991],"domain_scores_gemma":[0.9984441,0.0003356383,0.0002502288,0.0004382503,0.0001797032,0.0003520761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09858517,0.00043264,0.811354,0.0001372755,0.01268995,0.00008437686,0.001698528,0.02308345,0.00008218853,0.00001981715,0.00249422,0.04933839],"study_design_scores_gemma":[0.06503425,0.001421596,0.9105535,0.001050268,0.002290585,0.00003095361,0.0001714668,0.0006628934,0.00003197746,0.00001575444,0.01850157,0.000235245],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951738,0.001604952,0.0008991945,0.0001358334,0.0002615313,0.001111061,0.0006429752,0.00002246232,0.0001481581],"genre_scores_gemma":[0.9926637,0.00005265626,0.005898593,0.0001494305,0.001058604,0.000004895683,0.00008805089,0.00005444268,0.00002966609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09919943,"threshold_uncertainty_score":0.5048831,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02304786823365794,"score_gpt":0.2479306605782584,"score_spread":0.2248827923446004,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}